Literature DB >> 21769986

Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Geraldine H Kang1, Irene Cruite, Masoud Shiehmorteza, Tanya Wolfson, Anthony C Gamst, Gavin Hamilton, Mark Bydder, Michael S Middleton, Claude B Sirlin.   

Abstract

PURPOSE: To evaluate magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF) reproducibility across two MR scanner platforms and, using MR spectroscopy (MRS)-determined PDFF as reference standard, to confirm MRI-determined PDFF estimation accuracy.
MATERIALS AND METHODS: This prospective, cross-sectional, crossover, observational pilot study was approved by an Institutional Review Board. Twenty-one subjects gave written informed consent and underwent liver MRI and MRS at both 1.5T (Siemens Symphony scanner) and 3T (GE Signa Excite HD scanner). MRI-determined PDFF was estimated using an axial 2D spoiled gradient-recalled echo sequence with low flip-angle to minimize T1 bias and six echo-times to permit correction of T2* and fat-water signal interference effects. MRS-determined PDFF was estimated using a stimulated-echo acquisition mode sequence with long repetition time to minimize T1 bias and five echo times to permit T2 correction. Interscanner reproducibility of MRI determined PDFF was assessed by correlation analysis; accuracy was assessed separately at each field strength by linear regression analysis using MRS-determined PDFF as reference standard.
RESULTS: 1.5T and 3T MRI-determined PDFF estimates were highly correlated (r = 0.992). MRI-determined PDFF estimates were accurate at both 1.5T (regression slope/intercept = 0.958/-0.48) and 3T (slope/intercept = 1.020/0.925) against the MRS-determined PDFF reference.
CONCLUSION: MRI-determined PDFF estimation is reproducible and, using MRS-determined PDFF as reference standard, accurate across two MR scanner platforms at 1.5T and 3T.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21769986      PMCID: PMC4803481          DOI: 10.1002/jmri.22701

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  30 in total

Review 1.  MR spectroscopy quantitation: a review of time-domain methods.

Authors:  L Vanhamme; T Sundin; P V Hecke; S V Huffel
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

2.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals.

Authors:  A Naressi; C Couturier; I Castang; R de Beer; D Graveron-Demilly
Journal:  Comput Biol Med       Date:  2001-07       Impact factor: 4.589

Review 3.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

5.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

6.  Multiecho MR imaging and proton MR spectroscopy for liver fat quantification.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Pierre Cercueil; Denis Krause
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

7.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

8.  Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.

Authors:  Jürgen Machann; Claus Thamer; Birgit Schnoedt; Norbert Stefan; Hans-Ulrich Haring; Claus D Claussen; Andreas Fritsche; Fritz Schick
Journal:  Magn Reson Med       Date:  2006-04       Impact factor: 4.668

9.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

10.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

View more
  75 in total

Review 1.  Advanced imaging techniques for chronic pancreatitis.

Authors:  Anushri Parakh; Temel Tirkes
Journal:  Abdom Radiol (NY)       Date:  2020-05

2.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

3.  Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.

Authors:  Kevin A Zand; Amol Shah; Elhamy Heba; Tanya Wolfson; Gavin Hamilton; Jessica Lam; Joshua Chen; Jonathan C Hooker; Anthony C Gamst; Michael S Middleton; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2015-04-03       Impact factor: 4.813

4.  Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.

Authors:  Susanne Bonekamp; An Tang; Arian Mashhood; Tanya Wolfson; Christopher Changchien; Michael S Middleton; Lisa Clark; Anthony Gamst; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-06       Impact factor: 4.813

5.  How bariatric surgery affects liver volume and fat density in NAFLD patients.

Authors:  Ran B Luo; Toshiaki Suzuki; Jonathan C Hooker; Yesenia Covarrubias; Alexandra Schlein; Shanglei Liu; Jeffrey B Schwimmer; Scott B Reeder; Luke M Funk; Jacob A Greenberg; Guilherme M Campos; Bryan J Sandler; Santiago Horgan; Claude B Sirlin; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

6.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

7.  Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Authors:  N S Patel; M R Peterson; D A Brenner; E Heba; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2013-02-05       Impact factor: 8.171

Review 8.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

9.  MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.

Authors:  Guido Ligabue; Giulia Besutti; Riccardo Scaglioni; Chiara Stentarelli; Giovanni Guaraldi
Journal:  Quant Imaging Med Surg       Date:  2013-08

Review 10.  Evidence and recommendations for imaging liver fat in children, based on systematic review.

Authors:  Hannah I Awai; Kimberly P Newton; Claude B Sirlin; Cynthia Behling; Jeffrey B Schwimmer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-30       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.